Interview with Shiv Bhasin , President Director, Solvay pharma Indonesia
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
Address: Wisma 46 Kota Bni 12 FL Suite 12.01, JL. Jend Sudirman Kav 1, Jakarta 10220,Indonesia
Tel: 62/21/5746262
Web: http://www.solvayasiapacific.com/EN/Home.aspx
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
Pfizer has been one of the earliest believers in the Indonesian market, establishing its presence since 1969. As the number one MNC in Indonesia, how would you assess the current…
You have been working at Kalbe for 38 years, and as President Director for 11 years. What has it been like to see the firm transform from a company based…
Pyridam Farma has achieved and maintained the leading position in terms of growth in the Indonesian pharmaceutical industry for two years. What strategic choices have caused Pyridam to outperform its…
Overall health indicators have improved significantly in Indonesia in recent years. However, the country still faces many challenges and there are many areas in need of further improvement. What is…
How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes…
Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade?…
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
The development of the Local Pharmaceutical industry companies has gone through rough times, competing from the very beginning with MNCs and going through the economic shock in the 90’s. In…
Local firms have assumed an increasing role in the Indonesian pharmaceutical market representing today more than 75% of the market share and being able to provide over 90% of the…
How challenging is it being for you to adapt to the Indonesian business mindset. My adaptation to Indonesia has been relatively smooth thanks to my past experience in different Asian…
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
After 20 years experience with Boehringer Ingelheim, what would you say are the main specificities of the Indonesian pharmaceutical industry? Indonesia differs some what from other Asian countries, starting from…
See our Cookie Privacy Policy Here
